CKD-aP: Beyond the Surface
Leonie Kraft, MD
Decoding Itch in CKD: From CKD-aP Suspicion to Solution
James Burton, DM, FRCP
Lucio Manenti, MD, PhD
Emilio Sanchez, MD, PhD
Elevating CKD-aP Care: New Frontier
CKD-aP or Something Else? Decoding the Diagnosis
The Patient-Clinician Connection in Managing CKD-aP
FSGS: When Solutions Fall Short
Meghan Sise, MD
Current FSGS Treatment Landscape: More Questions Than Answers
Vladimir Tesar
FSGS: Interpretation of Proteinuria Reduction Thresholds
FSGS 360°: From Patient Experience to Precision Medicine
Kenneth Lieberman, MD
Treatment Considerations for Pediatric Patients With FSGS
Emerging Therapies in Managing Adult and Pediatric Patients With FSGS: Latest Data
Monitoring FSGS: Traditional and Novel Biomarkers
The Clinical Weight of TTR: What the Latest Data Reveal
Ahmad Masri, MD, MS
Rola Khedraki, MD
Optimizing IgAN Care: Achieving Lower Proteinuria Targets With Combination Therapy
Jonathan Barratt, MD, PhD
Sydney Tang, MBBS, MD
Modern Neuromodulation: Vagus Nerve Stimulation in Advancing Care for Patients With Drug-Resistant Epilepsy and Treatment-Resistant Depression
Raman Sankar, MD, PhD
Scott Aaronson, MD
Optimizing VNS Parameters: Keys to Therapeutic Success